Michael F. Mahoney - 12 Feb 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: Chairman, President & CEO, Director
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 12 Feb 2025
Net transactions value: -$700,832
Form type: 4
Filing time: 14 Feb 2025, 17:29:54 UTC
Previous filing: 13 Feb 2025
Next filing: 18 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+13,704	+0.85%	$0.000000	1,633,577	12 Feb 2025	Direct	F1
transaction	BSX	Common Stock	Tax liability	$700,832	-6,626	-0.41%	$105.77	1,626,951	12 Feb 2025	Direct
holding	BSX	Common Stock						201,478	12 Feb 2025	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Restricted Stock Units	Options Exercise	$0	-13,704	-25%	$0.000000	41,112	12 Feb 2025	Common Stock	13,704		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.